These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9934985)
1. Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Shaag A; Saada A; Berger I; Mandel H; Joseph A; Feigenbaum A; Elpeleg ON Am J Med Genet; 1999 Jan; 82(2):177-82. PubMed ID: 9934985 [TBL] [Abstract][Full Text] [Related]
2. Lipoamide dehydrogenase deficiency due to a novel mutation in the interface domain. Shany E; Saada A; Landau D; Shaag A; Hershkovitz E; Elpeleg ON Biochem Biophys Res Commun; 1999 Aug; 262(1):163-6. PubMed ID: 10448086 [TBL] [Abstract][Full Text] [Related]
3. Lipoamide dehydrogenase deficiency in Ashkenazi Jews: an insertion mutation in the mitochondrial leader sequence. Elpeleg ON; Shaag A; Glustein JZ; Anikster Y; Joseph A; Saada A Hum Mutat; 1997; 10(3):256-7. PubMed ID: 9298831 [No Abstract] [Full Text] [Related]
4. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737 [TBL] [Abstract][Full Text] [Related]
5. Short-chain acyl-CoA dehydrogenase gene mutation (c.319C>T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin. Tein I; Elpeleg O; Ben-Zeev B; Korman SH; Lossos A; Lev D; Lerman-Sagie T; Leshinsky-Silver E; Vockley J; Berry GT; Lamhonwah AM; Matern D; Roe CR; Gregersen N Mol Genet Metab; 2008 Feb; 93(2):179-89. PubMed ID: 18054510 [TBL] [Abstract][Full Text] [Related]
6. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy. Kollberg G; Tulinius M; Melberg A; Darin N; Andersen O; Holmgren D; Oldfors A; Holme E Brain; 2009 Aug; 132(Pt 8):2170-9. PubMed ID: 19567699 [TBL] [Abstract][Full Text] [Related]
7. Novel mutations in a boy with dihydrolipoamide dehydrogenase deficiency. Cerna L; Wenchich L; Hansiková H; Kmoch S; Peskova K; Chrastina P; Brynda J; Zeman J Med Sci Monit; 2001; 7(6):1319-25. PubMed ID: 11687750 [TBL] [Abstract][Full Text] [Related]
8. Biochemical and molecular diagnosis of lipoamide dehydrogenase deficiency in a North American Ashkenazi Jewish family. Sansaricq C; Pardo S; Balwani M; Grace M; Raymond K J Inherit Metab Dis; 2006 Feb; 29(1):203-4. PubMed ID: 16601893 [TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency. Odièvre MH; Chretien D; Munnich A; Robinson BH; Dumoulin R; Masmoudi S; Kadhom N; Rötig A; Rustin P; Bonnefont JP Hum Mutat; 2005 Mar; 25(3):323-4. PubMed ID: 15712224 [TBL] [Abstract][Full Text] [Related]
14. ATP synthesis in lipoamide dehydrogenase deficiency. Saada A; Aptowitzer I; Link G; Elpeleg ON Biochem Biophys Res Commun; 2000 Mar; 269(2):382-6. PubMed ID: 10708561 [TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency. Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992 [TBL] [Abstract][Full Text] [Related]
17. Molecular and biochemical investigations in fumarase deficiency. Deschauer M; Gizatullina Z; Schulze A; Pritsch M; Knöppel C; Knape M; Zierz S; Gellerich FN Mol Genet Metab; 2006 Jun; 88(2):146-52. PubMed ID: 16510303 [TBL] [Abstract][Full Text] [Related]
18. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195 [TBL] [Abstract][Full Text] [Related]
19. Liver disease in the Ashkenazi-Jewish lipoamide dehydrogenase deficiency. Aptowitzer I; Saada A; Faber J; Kleid D; Elpeleg ON J Pediatr Gastroenterol Nutr; 1997 May; 24(5):599-601. PubMed ID: 9161958 [No Abstract] [Full Text] [Related]
20. Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome. Brassier A; Ottolenghi C; Boutron A; Bertrand AM; Valmary-Degano S; Cervoni JP; Chrétien D; Arnoux JB; Hubert L; Rabier D; Lacaille F; de Keyzer Y; Di Martino V; de Lonlay P Mol Genet Metab; 2013 May; 109(1):28-32. PubMed ID: 23478190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]